摘要
目的评价DD3(Pca3)检测在前列腺腺癌活检标本病理诊断中的应用价值。方法观察DD3(Pca3)基因在196例前列腺腺癌和相关疾病前列腺标本中的原位杂交表达情况。结果在149例前列腺腺癌病例中,DD3(Pca3)染色阳性率为94.6%,染色情况与Gleason评分、患病年龄、血清总PSA值的关系无统计学意义。52例癌周有前列腺上皮内肿瘤(PIN)4,7例DD3(Pca3)阳性;149例腺癌癌巢周18例DD3(Pca3)阳性。在42例良性前列腺增生(BPH)中1例DD3(Pca3)阳性(2.38%)。结论 DD3(Pca3)是诊断前列腺腺癌有价值的阳性标记物。
Objective To evaluate the specificity and sensitivity of DD3 (Pea3) in detection of prostatic adenocarcinomas. Methods The expression of DD3 ( Pca3 ) was detected by in situ hybridization in 196 cases of prostatic adenocareinomas,42 cases of benign prostatic hyperplasia and 5 cases of atypical small acinar proliferation. Results DD3 (Pca3)RNA was positive in 94.6% cases of prostatic adenocarcinomas, regardless of Gleason score, age and serum PSA. However, DD3 ( Pca3 ) was also positive in high grade PIN that surrounded adeno- carcinomas (n = 52) ,47cases showed positive expression. In 149 cases of prostatic carcinoma, some normal-appearing glands situated in the immediate vicinity of cancer glands showed Pca3 expression. In 42 cases of BPH, lcases (2.38%) showed positive expression. Conclusion DD3 (Pca3)is a positive marker for diagnosis of prostatic adenocarcinomas,which has high sensitivity and specificity.
出处
《咸宁学院学报(医学版)》
2011年第4期299-301,共3页
Journal of Xianning Univarsity(medical Sciences)
基金
深圳市科技项目(20080036)